Joanne M. Donovan, CMO at Edgewise Therapeutics, Inc. (EWTX), sold 55,230 shares at $31.29 ($2.1M) on 2026-05-04, disclosed to the SEC on 2026-05-05.
Scheduled sale ($2.1M) by CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.29 | 5,230 | $164K | 7.8% |
| 2 | $38.57 | 50,000 | $1.9M | 92.2% |
| Total | $37.88 avg | 55,230 | $2.1M | 100% |
| Filing → |
| EWTX | SELL | 2026-03-31 | $1.4M | — | Filing → |
| EWTX | SELL | 2026-03-30 | $1.0M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $38K | — | Filing → |